{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:43:01Z","timestamp":1773301381805,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Behav Brain Funct"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The apolipoprotein E (APOE) and tau proteins play important roles in the pathological development of Alzheimer's disease (AD). Many studies have shown an association between the <jats:italic>APOE<\/jats:italic> gene and AD. Association between AD and the newly discovered saitohin (<jats:italic>STH<\/jats:italic>) gene, nested within the intron of the tau gene, has been reported. The present study aimed to elucidate the association between <jats:italic>APOE<\/jats:italic> and AD, and between <jats:italic>STH<\/jats:italic> and AD in our sample.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The functional polymorphisms, rs429358 and rs7412, in the <jats:italic>APOE<\/jats:italic> gene (which together define the <jats:italic>\u03b5<\/jats:italic> 2, <jats:italic>\u03b5<\/jats:italic> 3, and <jats:italic>\u03b5<\/jats:italic> 4 alleles), and the Q7R SNP in the <jats:italic>STH<\/jats:italic> gene, were genotyped in 369 patients with AD and 289 healthy European-Americans. The associations between these two genes and AD were analyzed in a case-control design.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Consistent with previously reported results, the frequencies of the <jats:italic>APOE \u03b5<\/jats:italic> 4 allele, <jats:italic>\u03b5<\/jats:italic> 4\/<jats:italic>\u03b5<\/jats:italic> 4 genotype and <jats:italic>\u03b5<\/jats:italic> 3\/<jats:italic>\u03b5<\/jats:italic> 4 genotype were significantly higher in AD cases than controls; the <jats:italic>\u03b5<\/jats:italic> 4\/<jats:italic>\u03b5<\/jats:italic> 4 genotype frequency was significantly higher in early-onset AD (EOAD) than late-onset AD (LOAD); the frequencies of the <jats:italic>\u03b5<\/jats:italic> 2 allele, <jats:italic>\u03b5<\/jats:italic> 3 allele, <jats:italic>\u03b5<\/jats:italic> 3\/<jats:italic>\u03b5<\/jats:italic> 3 genotype and <jats:italic>\u03b5<\/jats:italic> 2\/<jats:italic>\u03b5<\/jats:italic> 3 genotype were significantly lower in AD cases than controls. Positive likelihood ratios (LRs<jats:sup>+<\/jats:sup>) of <jats:italic>APOE<\/jats:italic> alleles and genotypes increased in a linear trend with the number of <jats:italic>\u03b5<\/jats:italic> 4 alleles and decreased in a linear trend with the number of <jats:italic>\u03b5<\/jats:italic> 2 or <jats:italic>\u03b5<\/jats:italic> 3 alleles. There was no significant difference in the <jats:italic>STH<\/jats:italic> allele and genotype frequency distributions between AD cases and controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study confirmed that the <jats:italic>\u03b5<\/jats:italic> 4 allele is a dose-response risk factor for AD and the <jats:italic>\u03b5<\/jats:italic> 4\/<jats:italic>\u03b5<\/jats:italic> 4 genotype was associated with a significantly earlier age of onset. Moreover, we found that the <jats:italic>\u03b5<\/jats:italic> 2 allele was a dose-response protective factor for AD and the <jats:italic>\u03b5<\/jats:italic> 3 allele exerted a weaker dose-response protective effect for risk of AD compared with <jats:italic>\u03b5<\/jats:italic> 2. In a clinical setting, <jats:italic>APOE<\/jats:italic> genotyping could offer additional biological evidence of whether a subject may develop AD, but it is not robust enough to serve as an independent screening or predictive test in the diagnosis of AD. <jats:italic>STH<\/jats:italic> variation was not significantly associated with AD in our sample.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1744-9081-2-13","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T14:31:48Z","timestamp":1145543508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Variation at APOE and STH loci and Alzheimer's disease"],"prefix":"10.1186","volume":"2","author":[{"given":"Lingjun","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H","family":"van Dyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingguang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry R","family":"Kranzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-zhu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Gelernter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,4,7]]},"reference":[{"key":"38_CR1","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"C Masters","year":"1985","unstructured":"Masters C, Simms G, Weinman N, Multhaup G, McDonald B, Beyreuther K: Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc Natl Acad Sci USA. 1985, 82: 4245-4249. 10.1073\/pnas.82.12.4245.","journal-title":"Proc Natl Acad Sci USA"},{"key":"38_CR2","first-page":"9","volume-title":"Novum, Huddinge","author":"K Sennvik","year":"2002","unstructured":"Sennvik K: A study of \u03b2-secretase cleaved Alzheimer amyloid precursor protein. Novum, Huddinge. 2002, Sweden: Karolinska University Press, 9-"},{"key":"38_CR3","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","volume":"40","author":"RW Mahley","year":"1999","unstructured":"Mahley RW, Huang Y, Rall SC: Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res. 1999, 40: 1933-1949.","journal-title":"J Lipid Res"},{"key":"38_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","volume":"6","author":"L Puglielli","year":"2003","unstructured":"Puglielli L, Tanzi RE, Kovacs DM: Alzheimer's disease: the cholesterol connection. Nat Neurosci. 2003, 6: 345-351. 10.1038\/nn0403-345.","journal-title":"Nat Neurosci"},{"key":"38_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K: Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991, 541: 163-166. 10.1016\/0006-8993(91)91092-F.","journal-title":"Brain Res"},{"key":"38_CR6","doi-asserted-by":"publisher","first-page":"16119","DOI":"10.1021\/bi0017475","volume":"39","author":"GW Munson","year":"2000","unstructured":"Munson GW, Roher AE, Kuo YM, Gilligan SM, Reardon CA, Getz GS, LaDu MJ: SDS-Stable Complex Formation between Native Apolipoprotein E3 and \u03b2-Amyloid Peptides. Biochemistry. 2000, 39: 16119-16124. 10.1021\/bi0017475.","journal-title":"Biochemistry"},{"key":"38_CR7","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","volume":"83","author":"K Kosik","year":"1986","unstructured":"Kosik K, Joachim C, Selkoe DJ: Microtubule-associated protein tau (\u03c4) is a major antigenic component of paired helical filaments in Alzheimer's disease. Proc Natl Acad Sci. 1986, 83: 4044-4048. 10.1073\/pnas.83.11.4044.","journal-title":"Proc Natl Acad Sci"},{"key":"38_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/jama.279.10.751","volume":"279","author":"M Farrer","year":"1998","unstructured":"Farrer M, Skipper L, Berg M, Bisceglio G, Hanson M, Hardy J, Adam A, Gwinn-Hardy K, Aasly J: The tau H1 haplotype is associated and the risk of Alzheimer disease among African Americans, Whites, and Hispanics. J Am Med Assoc. 1998, 279: 751-755. 10.1001\/jama.279.10.751.","journal-title":"J Am Med Assoc"},{"key":"38_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0304-3940(99)00833-2","volume":"277","author":"L Lilius","year":"1999","unstructured":"Lilius L, Froelich Fabre S, Basun H, Forsell C, Axelman K, Mattila K, Andreadis A, Viitanen M, Winblad B, Fratiglioni L, Lannfelt L: Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease. Neurosci Lett. 1999, 277: 29-32. 10.1016\/S0304-3940(99)00833-2.","journal-title":"Neurosci Lett"},{"key":"38_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(99)00893-9","volume":"278","author":"MJ Bullido","year":"2000","unstructured":"Bullido MJ, Aldudo J, Frank A, Coria F, Avila J, Valdivieso F: A polymorphism in the tau gene associated with risk for Alzheimer's disease. Neurosci Lett. 2000, 278: 49-52. 10.1016\/S0304-3940(99)00893-9.","journal-title":"Neurosci Lett"},{"key":"38_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S0304-3940(01)02289-3","volume":"314","author":"C Russ","year":"2001","unstructured":"Russ C, Powell JF, Zhao J, Baker M, Hutton M, Crawford F, Mullan M, Roks G, Cruts M, Lovestone S: The microtubule associated protein Tau gene and Alzheimer's disease\u2013an association study and meta-analysis. Neurosci Lett. 2001, 314: 92-96. 10.1016\/S0304-3940(01)02289-3.","journal-title":"Neurosci Lett"},{"key":"38_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0304-3940(02)00742-5","volume":"330","author":"R De Silva","year":"2002","unstructured":"De Silva R, Hardy J, Crook J, Khan N, Graham EA, Morris CM, Wood NW, Lees AJ: The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease. Neurosci Lett. 2002, 330: 201-203. 10.1016\/S0304-3940(02)00742-5.","journal-title":"Neurosci Lett"},{"key":"38_CR13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-2275(20)38094-9","volume":"23","author":"VI Zannis","year":"1982","unstructured":"Zannis VI, Breslow JL, Utermann G, Mahley RW, Weisgraber KH, Havel RJ, Goldstein JL, Brown MS, Schonfeld G, Hazzard WR, Blum C: Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. Lipid Res. 1982, 23: 911-914.","journal-title":"Lipid Res"},{"key":"38_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/0169-328X(94)00233-5","volume":"29","author":"F Oyama","year":"1995","unstructured":"Oyama F, Shimada H, Oyama R, Ihara Y: Apolipoprotein E genotype, Alzheimer's pathologies and related gene expression in the aged population. Brain Res Mol Brain Res. 1995, 29: 92-98. 10.1016\/0169-328X(94)00233-5.","journal-title":"Brain Res Mol Brain Res"},{"key":"38_CR15","first-page":"529","volume":"37","author":"GI Korovaitseva","year":"2001","unstructured":"Korovaitseva GI, Shcherbatykh TV, Selezneva NV, Gavrilova SI, Golimbet VE, Voskresenskaia NI, Rogachev EI: Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease. Genetika. 2001, 37: 529-535.","journal-title":"Genetika"},{"key":"38_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000068480","volume":"15","author":"O Combarros","year":"2003","unstructured":"Combarros O, Garcia-Roman M, Fontalba A, Fernandez-Luna JL, Llorca J, Infante J, Berciano J: Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease. Dement Geriatr Cogn Disord. 2003, 15: 151-154. 10.1159\/000068480.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"38_CR17","first-page":"349","volume":"55","author":"W Marui","year":"2003","unstructured":"Marui W, Iseki E, Sugiyama N, Matsumura T, Suzuki K, Odawara T, Hino H, Kosaka K: A Japanese family with familial Alzheimer's disease associated with presenilin 1 mutation: relationship between younger age of onset and ApoE gene polymorphism. No To Shinkei. 2003, 55: 349-353.","journal-title":"No To Shinkei"},{"key":"38_CR18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993, 261: 921-923.","journal-title":"Science"},{"key":"38_CR19","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1212\/WNL.57.10.1923","volume":"57","author":"FC Goldstein","year":"2001","unstructured":"Goldstein FC, Ashley AV, Gearing M, Hanfelt J, Penix L, Freedman LJ, Levey AI: Apolipoprotein E and age at onset of Alzheimer's disease in African American patients. Neurology. 2001, 57: 1923-1925.","journal-title":"Neurology"},{"key":"38_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ana.10093","volume":"51","author":"E Mori","year":"2002","unstructured":"Mori E, Lee K, Yasuda M, Hashimoto M, Kazui H, Hirono N, Matsui M: Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. Ann Neurol. 2002, 51: 209-214. 10.1002\/ana.10093.","journal-title":"Ann Neurol"},{"key":"38_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1212\/01.WNL.0000073140.25533.90","volume":"61","author":"R De Silva","year":"2003","unstructured":"De Silva R, Hope A, Pittman A, Weale ME, Morris HR, Wood NW, Lees AJ: Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy. Neurology. 2003, 61: 407-409.","journal-title":"Neurology"},{"key":"38_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0304-3940(03)00788-2","volume":"348","author":"B Peplonska","year":"2003","unstructured":"Peplonska B, Zekanowski C, Religa D, Czyzewski K, Styczynska M, Pfeffer A, Gabryelewicz T, Golebiowski M, Luczywek E, Wasiak B, Barczak A, Chodakowska M, Barcikowska M, Kuznicki J: Strong association between Saitohin gene polymorphism and tau haplotype in the Polish population. Neurosci Lett. 2003, 348: 163-166. 10.1016\/S0304-3940(03)00788-2.","journal-title":"Neurosci Lett"},{"key":"38_CR23","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1073\/pnas.112194599","volume":"99","author":"C Conrad","year":"2002","unstructured":"Conrad C, Vianna C, Freeman M, Davies P: A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease. Proc Natl Acad Sci USA. 2002, 99: 7751-7756. 10.1073\/pnas.112194599.","journal-title":"Proc Natl Acad Sci USA"},{"key":"38_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000071000","volume":"16","author":"O Combarros","year":"2003","unstructured":"Combarros O, Rodero L, Infante J, Palacio E, Llorca J, Fernandez-Viadero C, Pena N, Berciano J: Age-dependent association between the Q7R polymorphism in the Saitohin gene and sporadic Alzheimer's disease. Dement Geriatr Cogn Disord. 2003, 16: 132-135. 10.1159\/000071000.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"38_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/archneur.59.6.935","volume":"59","author":"P Verpillat","year":"2002","unstructured":"Verpillat P, Camuzat A, Hannequin D, Thomas-Anterion C, Puel M, Belliard S, Dubois B, Didic M, Michel BF, Lacomblez L, Moreaud O, Sellal F, Golfier V, Campion D, Clerget-Darpoux F, Brice A: Association between the extended tau haplotype and frontotemporal dementia. Arch Neurol. 2002, 59: 935-939. 10.1001\/archneur.59.6.935.","journal-title":"Arch Neurol"},{"key":"38_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000070999","volume":"16","author":"C Zekanowski","year":"2003","unstructured":"Zekanowski C, Peplonska B, Styczynska M, Gustaw K, Kuznicki J, Barcikowska M: Mutation screening of the MAPT and STH genes in Polish patients with clinically diagnosed frontotemporal dementia. Dement Geriatr Cogn Disord. 2003, 16: 126-131. 10.1159\/000070999.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"38_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/jnnp.74.3.362","volume":"74","author":"JR Streffer","year":"2003","unstructured":"Streffer JR, Papassotiropoulos A, Kurosinski P, Signorell A, Wollmer MA, Tsolaki M, Iakovidou V, H\u00f6rndli F, Bosset J, G\u00f6tz J, Nitsch RM, Hock C: Saitohin gene is not associated with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003, 74: 362-363. 10.1136\/jnnp.74.3.362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"38_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0304-3940(03)00635-9","volume":"347","author":"LN Clark","year":"2003","unstructured":"Clark LN, Levy G, Tang MX, Mejia-Santana H, Ciappa A, Tycko B, Cote LJ, Louis ED, Mayeux R, Marder K: The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts. Neurosci Lett. 2003, 347: 17-20. 10.1016\/S0304-3940(03)00635-9.","journal-title":"Neurosci Lett"},{"key":"38_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0304-3940(03)00670-0","volume":"347","author":"SA Oliveira","year":"2003","unstructured":"Oliveira SA, Martin ER, Scott WK, Nicodemus KK, Small GW, Schmechel DE, Doraiswamy PM, Roses AD, Saunders AM, Gilbert JR, Haines JL, Vance JM, Pericak-Vance MA: The Q7R Saitohin gene polymorphism is not associated with Alzheimer disease. Neurosci Lett. 2003, 347: 143-146. 10.1016\/S0304-3940(03)00670-0.","journal-title":"Neurosci Lett"},{"key":"38_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1989","unstructured":"McKhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology. 1989, 34: 939-944.","journal-title":"Neurology"},{"key":"38_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/S0033291700003081","volume":"14","author":"JCS Breitner","year":"1984","unstructured":"Breitner JCS, Folstein MF: Familial Alzheimer's disease: a prevalent disorder with specific clinical features. Psychol Med. 1984, 14: 63-80.","journal-title":"Psychol Med"},{"key":"38_CR32","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1176\/ajp.143.10.1279","volume":"143","author":"JM Silverman","year":"1986","unstructured":"Silverman JM, Breitner JCS, Mohs RC, Davis KL: Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry. 1986, 143: 1279-1282.","journal-title":"Am J Psychiatry"},{"key":"38_CR33","volume-title":"New York: New York Biometrics Research Division","author":"RL Spitzer","year":"1975","unstructured":"Spitzer RL, Endicott J: Schedule for Affective Disorders and Schizophrenia: Lifetime version. New York: New York Biometrics Research Division. 1975, New York State Psychiatric Institute"},{"key":"38_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR: \"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-198. 10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res"},{"key":"38_CR35","first-page":"643","volume":"54","author":"MS Tsai","year":"1994","unstructured":"Tsai MS, Tangalos EG, Petersen RC, Smith GE, Schaid DJ, Kokmen E, Ivnik RJ, Thibodeau SN: Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet. 1994, 54: 643-649.","journal-title":"Am J Hum Genet"},{"key":"38_CR36","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S: A Simple sequentially rejective multiple test procedure. Scand J Stat. 1979, 6: 65-70.","journal-title":"Scand J Stat"},{"key":"38_CR37","volume-title":"Fundamentals of Biostatistics","author":"B Rosner","year":"1979","unstructured":"Rosner B: Fundamentals of Biostatistics. 1979, Australia: Duxbury, 5","edition":"5"},{"key":"38_CR38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/oxfordjournals.aje.a114548","volume":"125","author":"RI Pfeffer","year":"1987","unstructured":"Pfeffer RI, Afifi AA, Chance JM: Prevalence of Alzheimer's disease in a retirement community. Am J Epidemiol. 1987, 125: 420-436.","journal-title":"Am J Epidemiol"},{"key":"38_CR39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/978-1-4757-3514-7","volume-title":"Evidence-Based Diagnosis: a handbook of clinical prediction rules","author":"MH Ebell","year":"2001","unstructured":"Ebell MH: Evidence-Based Diagnosis: a handbook of clinical prediction rules. 2001, New York: Springer, 6-8."},{"key":"38_CR40","volume-title":"Richardson, TX: Epistat Services","author":"TL Gustafson","year":"1992","unstructured":"Gustafson TL: True Epistat Version 6.0. Richardson, TX: Epistat Services. 1992"},{"key":"38_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0304-3940(97)00538-7","volume":"231","author":"B Palumbo","year":"1997","unstructured":"Palumbo B, Parnetti L, Nocentini G, Cardinali L, Brancorsini S, Riccardi C, Senin U: Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. Neurosci Lett. 1997, 231: 59-61. 10.1016\/S0304-3940(97)00538-7.","journal-title":"Neurosci Lett"},{"key":"38_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/00002093-199910000-00007","volume":"13","author":"PM Bretsky","year":"1999","unstructured":"Bretsky PM, Buckwalter JG, Seeman TE, Miller CA, Poirier J, Schellenberg GD, Finch CE, Henderson VW: Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord. 1999, 13: 216-221.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"38_CR43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1590\/S0100-879X2000000500007","volume":"33","author":"FM De-Andrade","year":"2000","unstructured":"De-Andrade FM, Larrandaburu M, Callegari-Jacques SM, Gastaldo G, Hutz MH: Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population. Braz J Med Biol Res. 2000, 33: 529-537. 10.1590\/S0100-879X2000000500007.","journal-title":"Braz J Med Biol Res"},{"key":"38_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00702-003-0071-1","volume":"111","author":"F Panza","year":"2004","unstructured":"Panza F, Introno AD, Colacicca AM, Basile AM, Capurso C, Kehoe PG, Capurso A, Solfrizzi V: Vascular risk and genetics of Sporadic Late-Onset Alzheimer's Disease. J Neural Transm. 2004, 111: 69-89. 10.1007\/s00702-003-0071-1.","journal-title":"J Neural Transm"},{"key":"38_CR45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3233\/JAD-2002-4303","volume":"4","author":"JW Ashford","year":"2002","unstructured":"Ashford JW: ApoE: Is it the absence of good or the presence of bad?. J Alzheimer Dis. 2002, 4: 141-143.","journal-title":"J Alzheimer Dis"}],"container-title":["Behavioral and Brain Functions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1744-9081-2-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T23:39:49Z","timestamp":1630453189000},"score":1,"resource":{"primary":{"URL":"https:\/\/behavioralandbrainfunctions.biomedcentral.com\/articles\/10.1186\/1744-9081-2-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1186\/1744-9081-2-13","relation":{},"ISSN":["1744-9081"],"issn-type":[{"value":"1744-9081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,7]]},"assertion":[{"value":"15 March 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"13"}}